Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRIVE-AF: Dronedarone Rhythm Intervention for Early Atrial Fibrillation
KCT0011162Phase 4Not yet recruiting
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dronedarone in Atrial fibrillation (AFib), sponsored by Samjin Pharmaceutical Co., Ltd.. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on KCT0011162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011162.